Skip to main content
Erschienen in: Heart and Vessels 8/2016

11.01.2016 | Original Article

Increased mortality and aggravation of heart failure in liver X receptor-α knockout mice after myocardial infarction

verfasst von: Xiaoqiang Liu, Jianshu Gao, Qiang Xia, Tianfei Lu, Fang Wang

Erschienen in: Heart and Vessels | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Liver X receptors, LXRα (NR1H3) and LXRβ (NR1H2), are best known as nuclear oxysterol receptors and physiological master regulators of lipid and cholesterol metabolism. LXRα play a protective role in acute myocardial ischemia/reperfusion (MI/R) injury, but its role in myocardial infarction (MI) is unknown. The present study was undertaken to determine the effect of LXRα knockout on survival and development of chronic heart failure after MI. Wild-type (WT) and LXRα−/− mice were subjected to MI followed by serial echocardiographic and histological assessments. Greater myocyte apoptosis and inflammation within the infarcted zones were found in LXRα−/− group at 3 days after MI. At 4 weeks post-MI, LXRα−/− MI murine hearts demonstrated significantly increased infarct size, reduced ejection fraction (LXRα−/− 29.4 % versus WT 34.4 %), aggravated left ventricular (LV) chamber dilation, enhanced fibrosis and reduced angiogenesis. In addition, LXRα−/− mice had increased mortality compared with WT mice. LXRα deficiency increases mortality, aggravates pathological injury and LV remodeling induced by MI. Drugs specifically targeting LXRα may be promising in the treatment of MI.
Literatur
1.
Zurück zum Zitat Pu J, Mintz GS, Brilakis ES, Banerjee S, Abdel-Karim AR, Maini B, Biro S, Lee JB, Stone GW, Weisz G, Maehara A (2012) In vivo characterization of coronary plaques: novel findings from comparing greyscale and virtual histology intravascular ultrasound and near-infrared spectroscopy. Eur Heart J 33:372–383CrossRefPubMed Pu J, Mintz GS, Brilakis ES, Banerjee S, Abdel-Karim AR, Maini B, Biro S, Lee JB, Stone GW, Weisz G, Maehara A (2012) In vivo characterization of coronary plaques: novel findings from comparing greyscale and virtual histology intravascular ultrasound and near-infrared spectroscopy. Eur Heart J 33:372–383CrossRefPubMed
2.
Zurück zum Zitat Zhang BH, Guo CX, Wang HX, Lu LQ, Wang YJ, Zhang LK, Du FH, Zeng XJ (2014) Cardioprotective effects of adipokine apelin on myocardial infarction. Heart Vessels 29:679–689CrossRefPubMed Zhang BH, Guo CX, Wang HX, Lu LQ, Wang YJ, Zhang LK, Du FH, Zeng XJ (2014) Cardioprotective effects of adipokine apelin on myocardial infarction. Heart Vessels 29:679–689CrossRefPubMed
3.
Zurück zum Zitat Cabiati M, Martino A, Mattii L, Caselli C, Prescimone T, Lionetti V, Morales MA, Del Ry S (2014) Adenosine receptor expression in an experimental animal model of myocardial infarction with preserved left ventricular ejection fraction. Heart Vessels 29:513–519CrossRefPubMed Cabiati M, Martino A, Mattii L, Caselli C, Prescimone T, Lionetti V, Morales MA, Del Ry S (2014) Adenosine receptor expression in an experimental animal model of myocardial infarction with preserved left ventricular ejection fraction. Heart Vessels 29:513–519CrossRefPubMed
4.
Zurück zum Zitat Gheorghiade M, Bonow RO (1998) Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 97:282–289CrossRefPubMed Gheorghiade M, Bonow RO (1998) Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 97:282–289CrossRefPubMed
6.
Zurück zum Zitat Jakobsson T, Treuter E, Gustafsson JA, Steffensen KR (2012) Liver X receptor biology and pharmacology: new pathways, challenges and opportunities. Trends Pharmacol Sci 33:394–404CrossRefPubMed Jakobsson T, Treuter E, Gustafsson JA, Steffensen KR (2012) Liver X receptor biology and pharmacology: new pathways, challenges and opportunities. Trends Pharmacol Sci 33:394–404CrossRefPubMed
7.
Zurück zum Zitat Kuipers I, Li J, Vreeswijk-Baudoin I, Koster J, van der Harst P, Sillje HH, Kuipers F, van Veldhuisen DJ, van Gilst WH, de Boer RA (2010) Activation of liver X receptors with T0901317 attenuates cardiac hypertrophy in vivo. Eur J Heart Fail 12:1042–1050CrossRefPubMed Kuipers I, Li J, Vreeswijk-Baudoin I, Koster J, van der Harst P, Sillje HH, Kuipers F, van Veldhuisen DJ, van Gilst WH, de Boer RA (2010) Activation of liver X receptors with T0901317 attenuates cardiac hypertrophy in vivo. Eur J Heart Fail 12:1042–1050CrossRefPubMed
8.
Zurück zum Zitat Wu S, Yin R, Ernest R, Li Y, Zhelyabovska O, Luo J, Yang Y, Yang Q (2009) Liver X receptors are negative regulators of cardiac hypertrophy via suppressing NF-κB signalling. Cardiovasc Res 84:119–126CrossRefPubMedPubMedCentral Wu S, Yin R, Ernest R, Li Y, Zhelyabovska O, Luo J, Yang Y, Yang Q (2009) Liver X receptors are negative regulators of cardiac hypertrophy via suppressing NF-κB signalling. Cardiovasc Res 84:119–126CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Lei P, Baysa A, Nebb HI, Valen G, Skomedal T, Osnes JB, Yang Z, Haugen F (2013) Activation of Liver X receptors in the heart leads to accumulation of intracellular lipids and attenuation of ischemia-reperfusion injury. Basic Res Cardiol 108:323CrossRefPubMed Lei P, Baysa A, Nebb HI, Valen G, Skomedal T, Osnes JB, Yang Z, Haugen F (2013) Activation of Liver X receptors in the heart leads to accumulation of intracellular lipids and attenuation of ischemia-reperfusion injury. Basic Res Cardiol 108:323CrossRefPubMed
10.
Zurück zum Zitat He Q, Pu J, Yuan A, Lau WB, Gao E, Koch WJ, Ma XL, He B (2014) Activation of liver-X-receptor alpha but not liver-X-receptor beta protects against myocardial ischemia/reperfusion injury. Circ Heart Fail 7:1032–1041CrossRefPubMedPubMedCentral He Q, Pu J, Yuan A, Lau WB, Gao E, Koch WJ, Ma XL, He B (2014) Activation of liver-X-receptor alpha but not liver-X-receptor beta protects against myocardial ischemia/reperfusion injury. Circ Heart Fail 7:1032–1041CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Gao E, Lei YH, Shang X, Huang ZM, Zuo L, Boucher M, Fan Q, Chuprun JK, Ma XL, Koch WJ (2010) A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ Res 107:1445–1453CrossRefPubMedPubMedCentral Gao E, Lei YH, Shang X, Huang ZM, Zuo L, Boucher M, Fan Q, Chuprun JK, Ma XL, Koch WJ (2010) A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ Res 107:1445–1453CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Tsuda T, Gao E, Evangelisti L, Markova D, Ma X, Chu ML (2003) Post-ischemic myocardial fibrosis occurs independent of hemodynamic changes. Cardiovasc Res 59:926–933CrossRefPubMed Tsuda T, Gao E, Evangelisti L, Markova D, Ma X, Chu ML (2003) Post-ischemic myocardial fibrosis occurs independent of hemodynamic changes. Cardiovasc Res 59:926–933CrossRefPubMed
13.
Zurück zum Zitat He K, Chen X, Han C, Xu L, Zhang J, Zhang M, Xia Q (2014) Lipopolysaccharide-induced cross-tolerance against renal ischemia-reperfusion injury is mediated by hypoxia-inducible factor-2alpha-regulated nitric oxide production. Kidney Int 85:276–288CrossRefPubMed He K, Chen X, Han C, Xu L, Zhang J, Zhang M, Xia Q (2014) Lipopolysaccharide-induced cross-tolerance against renal ischemia-reperfusion injury is mediated by hypoxia-inducible factor-2alpha-regulated nitric oxide production. Kidney Int 85:276–288CrossRefPubMed
14.
Zurück zum Zitat Matsui Y, Nakano N, Shao D, Gao S, Luo W, Hong C, Zhai P, Holle E, Yu X, Yabuta N, Tao W, Wagner T, Nojima H, Sadoshima J (2008) Lats2 is a negative regulator of myocyte size in the heart. Circ Res 103:1309–1318CrossRefPubMedPubMedCentral Matsui Y, Nakano N, Shao D, Gao S, Luo W, Hong C, Zhai P, Holle E, Yu X, Yabuta N, Tao W, Wagner T, Nojima H, Sadoshima J (2008) Lats2 is a negative regulator of myocyte size in the heart. Circ Res 103:1309–1318CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Abbate A, Biondi-Zoccai GG, Baldi A (2002) Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling. J Cell Physiol 193:145–153CrossRefPubMed Abbate A, Biondi-Zoccai GG, Baldi A (2002) Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling. J Cell Physiol 193:145–153CrossRefPubMed
16.
Zurück zum Zitat Nishida K, Kaziro Y, Satoh T (1999) Anti-apoptotic function of Rac in hematopoietic cells. Oncogene 18:407–415CrossRefPubMed Nishida K, Kaziro Y, Satoh T (1999) Anti-apoptotic function of Rac in hematopoietic cells. Oncogene 18:407–415CrossRefPubMed
17.
Zurück zum Zitat Frangogiannis NG (2006) The mechanistic basis of infarct healing. Antioxid Redox Signal 8:1907–1939CrossRefPubMed Frangogiannis NG (2006) The mechanistic basis of infarct healing. Antioxid Redox Signal 8:1907–1939CrossRefPubMed
18.
Zurück zum Zitat Chen W, Frangogiannis NG (2013) Fibroblasts in post-infarction inflammation and cardiac repair. Biochim Biophys Acta 1833:945–953CrossRefPubMed Chen W, Frangogiannis NG (2013) Fibroblasts in post-infarction inflammation and cardiac repair. Biochim Biophys Acta 1833:945–953CrossRefPubMed
19.
Zurück zum Zitat Ahn A, Frishman WH, Gutwein A, Passeri J, Nelson M (2008) Therapeutic angiogenesis: a new treatment approach for ischemic heart disease–part I. Cardiol Rev 16:163–171CrossRefPubMed Ahn A, Frishman WH, Gutwein A, Passeri J, Nelson M (2008) Therapeutic angiogenesis: a new treatment approach for ischemic heart disease–part I. Cardiol Rev 16:163–171CrossRefPubMed
20.
Zurück zum Zitat Zhu H, Jiang X, Li X, Hu M, Wan W, Wen Y, He Y, Zheng X (2015) Intramyocardial delivery of VEGF via a novel biodegradable hydrogel induces angiogenesis and improves cardiac function after rat myocardial infarction. Heart Vessels. doi:10.1007/s00380-015-0710-0 Zhu H, Jiang X, Li X, Hu M, Wan W, Wen Y, He Y, Zheng X (2015) Intramyocardial delivery of VEGF via a novel biodegradable hydrogel induces angiogenesis and improves cardiac function after rat myocardial infarction. Heart Vessels. doi:10.​1007/​s00380-015-0710-0
21.
Zurück zum Zitat Cohn JN, Ferrari R, Sharpe N (2000) Cardiac remodeling–concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 35:569–582CrossRefPubMed Cohn JN, Ferrari R, Sharpe N (2000) Cardiac remodeling–concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 35:569–582CrossRefPubMed
22.
Zurück zum Zitat Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ (1995) LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 9:1033–1045CrossRefPubMed Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA, Mangelsdorf DJ (1995) LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 9:1033–1045CrossRefPubMed
24.
Zurück zum Zitat Wang Y, Li C, Cheng K, Zhang R, Narsinh K, Li S, Li X, Qin X, Zhang R, Li C, Su T, Chen J, Cao F (2014) Activation of liver X receptor improves viability of adipose-derived mesenchymal stem cells to attenuate myocardial ischemia injury through TLR4/NF-κB and Keap-1/Nrf-2 signaling pathways. Antioxid Redox Signal 21:2543–2557CrossRefPubMedPubMedCentral Wang Y, Li C, Cheng K, Zhang R, Narsinh K, Li S, Li X, Qin X, Zhang R, Li C, Su T, Chen J, Cao F (2014) Activation of liver X receptor improves viability of adipose-derived mesenchymal stem cells to attenuate myocardial ischemia injury through TLR4/NF-κB and Keap-1/Nrf-2 signaling pathways. Antioxid Redox Signal 21:2543–2557CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Pelzer T, Loza PA, Hu K, Bayer B, Dienesch C, Calvillo L, Couse JF, Korach KS, Neyses L, Ertl G (2005) Increased mortality and aggravation of heart failure in estrogen receptor-beta knockout mice after myocardial infarction. Circulation 111:1492–1498CrossRefPubMed Pelzer T, Loza PA, Hu K, Bayer B, Dienesch C, Calvillo L, Couse JF, Korach KS, Neyses L, Ertl G (2005) Increased mortality and aggravation of heart failure in estrogen receptor-beta knockout mice after myocardial infarction. Circulation 111:1492–1498CrossRefPubMed
26.
Zurück zum Zitat Tomaselli GF, Marban E (1999) Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res 42:270–283CrossRefPubMed Tomaselli GF, Marban E (1999) Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res 42:270–283CrossRefPubMed
27.
Zurück zum Zitat White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ (1987) Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76:44–51CrossRefPubMed White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ (1987) Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76:44–51CrossRefPubMed
28.
Zurück zum Zitat Gao F, Tao L, Yan W, Gao E, Liu HR, Lopez BL, Christopher TA, Ma XL (2004) Early anti-apoptosis treatment reduces myocardial infarct size after a prolonged reperfusion. Apoptosis 9:553–559CrossRefPubMed Gao F, Tao L, Yan W, Gao E, Liu HR, Lopez BL, Christopher TA, Ma XL (2004) Early anti-apoptosis treatment reduces myocardial infarct size after a prolonged reperfusion. Apoptosis 9:553–559CrossRefPubMed
29.
Zurück zum Zitat Sam F, Sawyer DB, Chang DL, Eberli FR, Ngoy S, Jain M, Amin J, Apstein CS, Colucci WS (2000) Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am J Physiol Heart Circ Physiol 279:H422–H428PubMed Sam F, Sawyer DB, Chang DL, Eberli FR, Ngoy S, Jain M, Amin J, Apstein CS, Colucci WS (2000) Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am J Physiol Heart Circ Physiol 279:H422–H428PubMed
30.
Zurück zum Zitat Li HL, Zhuo ML, Wang D, Wang AB, Cai H, Sun LH, Yang Q, Huang Y, Wei YS, Liu PP, Liu DP, Liang CC (2007) Targeted cardiac overexpression of A20 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circulation 115:1885–1894CrossRefPubMed Li HL, Zhuo ML, Wang D, Wang AB, Cai H, Sun LH, Yang Q, Huang Y, Wei YS, Liu PP, Liu DP, Liang CC (2007) Targeted cardiac overexpression of A20 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circulation 115:1885–1894CrossRefPubMed
31.
Zurück zum Zitat Manabe I, Shindo T, Nagai R (2002) Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res 91:1103–1113CrossRefPubMed Manabe I, Shindo T, Nagai R (2002) Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res 91:1103–1113CrossRefPubMed
32.
Zurück zum Zitat Martos R, Baugh J, Ledwidge M, O’Loughlin C, Conlon C, Patle A, Donnelly SC, McDonald K (2007) Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 115:888–895CrossRefPubMed Martos R, Baugh J, Ledwidge M, O’Loughlin C, Conlon C, Patle A, Donnelly SC, McDonald K (2007) Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 115:888–895CrossRefPubMed
33.
Zurück zum Zitat Boyle AJ, Kelly DJ, Zhang Y, Cox AJ, Gow RM, Way K, Itescu S, Krum H, Gilbert RE (2005) Inhibition of protein kinase C reduces left ventricular fibrosis and dysfunction following myocardial infarction. J Mol Cell Cardiol 39:213–221CrossRefPubMed Boyle AJ, Kelly DJ, Zhang Y, Cox AJ, Gow RM, Way K, Itescu S, Krum H, Gilbert RE (2005) Inhibition of protein kinase C reduces left ventricular fibrosis and dysfunction following myocardial infarction. J Mol Cell Cardiol 39:213–221CrossRefPubMed
34.
Zurück zum Zitat Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dyspersin GD, Cleutjens JP, Shipley M, Angellilo A, Levi M, Nube O, Baker A, Keshet E, Lupu F, Herbert JM, Smits JF, Shapiro SD, Baes M, Borgers M, Collen D, Daemen MJ, Carmeliet P (1999) Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 5:1135–1142CrossRefPubMed Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dyspersin GD, Cleutjens JP, Shipley M, Angellilo A, Levi M, Nube O, Baker A, Keshet E, Lupu F, Herbert JM, Smits JF, Shapiro SD, Baes M, Borgers M, Collen D, Daemen MJ, Carmeliet P (1999) Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 5:1135–1142CrossRefPubMed
35.
Zurück zum Zitat Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlethwaite PA (2000) Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 342:626–633CrossRefPubMed Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlethwaite PA (2000) Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 342:626–633CrossRefPubMed
36.
Metadaten
Titel
Increased mortality and aggravation of heart failure in liver X receptor-α knockout mice after myocardial infarction
verfasst von
Xiaoqiang Liu
Jianshu Gao
Qiang Xia
Tianfei Lu
Fang Wang
Publikationsdatum
11.01.2016
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 8/2016
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-015-0781-y

Weitere Artikel der Ausgabe 8/2016

Heart and Vessels 8/2016 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.